WHO officials: Chinas drug monitoring work has achieved remarkable results

Xinnuo Medicine 2018-09-27

The 37th World Health Organization International Drug Monitoring Cooperation Member State Annual Meeting of Xinhua News Agency was held in Tianjin on the 15th. During the meeting, Shanti, head of the WHO Drug Safety and Alert Team, said that China has made significant progress in monitoring adverse drug reactions and has made important contributions to international cooperation in this field.

According to reports, representatives from 53 countries and regions including China, the United States, and Japan participated in the annual meeting. This is the first time that China has hosted the annual meeting since joining the cooperation program in 1998.

“China has provided a large number of data reports for the global drug monitoring database.” Shanti said that China is also playing an important role in traditional drug production, consumption and international trade in the field of traditional drug adverse reaction monitoring including botanicals such as Chinese herbal medicine. The role.

Wu Hao, deputy director of the State Food and Drug Administration, said at the meeting that China has established three levels of monitoring institutions at the national, provincial and prefecture levels. In addition to the National Center, there are nearly 400 local monitoring agencies at all levels; the number of reporting users at the grassroots level of the Adverse Reaction Monitoring Information System has reached 150,000, and real-time online reporting of adverse reaction cases has been achieved. “In 2013, more than one million cases of adverse drug reactions were reported, and the role of drug safety evaluation and risk warning was gradually improved.”

When talking about the existing problems, Wu Hao said that China's drug monitoring and alerting work started late, the foundation is relatively weak, and there are still many challenges in drug safety evaluation and risk management. "Through this annual meeting, China can learn from the advanced experience of various countries and enhance the ability and level of drug monitoring and risk management. It is also hoped that countries will continue to strengthen exchanges and cooperation in this field in the future, and jointly safeguard the safety of public drug use and improve the safety. The health of the people of the world."

The reporter learned that in the early 1960s, "reaction stop" was widely used as a drug to relieve pregnancy reaction, resulting in the birth of a large number of "sea seal malformed babies". To this end, the World Health Organization established the International Drug Monitoring Cooperation Pilot Program in 1968 and established the International Drug Monitoring Cooperation Center. Strengthen global drug monitoring and alerting by collecting and communicating adverse drug reaction reports to ensure the safe use of drugs.